INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

CDNACareDx, Inc.

CIK 0001217234

EDGAR filingsOpen in network
Disclosed transactions48
Buys / sells0 / 12
Max Insider Score25
Connections9with evidence

CDNA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
CE
Cohen Fred EDirector
CDNACareDx, Inc.
Gift
G—
25.0K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8071 · Services-Medical Laboratories · Nov 4, 2026
  • ← Insider ofevidence
    Cohen Fred EDirector · Nov 4, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Gunasekaran SureshDirector · Jun 16, 2026
8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F
$247K
2,873 sh
Nov 1, 2026
Nov 3, 2026
traded Nov 1, 2026
+2d
SEC FORM 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$66K
997 sh
Oct 1, 2026Oct 5, 2026
traded Oct 1, 2026
+4dSEC FORM 4

Evidence

12
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Tax withholding
F$173K
2,619 sh
Oct 1, 2026Oct 5, 2026
traded Oct 1, 2026
+4dSEC FORM 4

Evidence

15
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Tax withholding
F$350K
6,688 sh
Sep 12, 2026Sep 15, 2026
traded Sep 12, 2026
+3dSEC FORM 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$29K
997 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC FORM 4

Evidence

12
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Tax withholding
F$71K
2,411 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC FORM 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$327K
39.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

6
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$2,900
100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$820
100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

8
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$129K
15.7K sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC FORM 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
13.6K sh
Jun 11, 2026Jun 30, 2026
traded Jun 11, 2026
+19dSEC FORM 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$5,789
706 sh
Jun 4, 2026Jun 30, 2026
traded Jun 4, 2026
+26dSEC FORM 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
15.7K sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC FORM 4

Evidence

0
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
39.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

8
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$112K
13.6K sh
Jun 11, 2026Jun 30, 2026
traded Jun 11, 2026
+19dSEC FORM 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
706 sh
Jun 4, 2026Jun 30, 2026
traded Jun 4, 2026
+26dSEC FORM 4

Evidence

19
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
39.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

24
VH
Valantine HannahDirector
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$280K
12.1K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

7
GS
Gunasekaran SureshDirector
CDNACareDx, Inc.
Grant or award · 10b5-1 plan
A—
9,795 sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC FORM 4

Evidence

7
VH
Valantine HannahDirector
CDNACareDx, Inc.
Grant or award · 10b5-1 plan
A—
9,795 sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC FORM 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$28K
1,292 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC FORM 4

Evidence

20
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$56K
2,688 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$62K
2,873 sh
May 1, 2026May 4, 2026
traded May 1, 2026
+3dSEC FORM 4

Evidence

4
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
10.3K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

18
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Tax withholding
F$1.09M
62.0K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$34K
1,892 sh
Apr 6, 2026Apr 7, 2026
traded Apr 6, 2026
+1dSEC FORM 4

Evidence

12
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Tax withholding
F$132K
7,386 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$71K
3,987 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

13
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Grant or award
A—
7,875 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

21
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Grant or award
A—
33.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$51K
2,492 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

13
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Grant or award
A—
33.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Grant or award
A—
4,342 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

12
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Tax withholding
F$90K
4,430 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

13
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Grant or award
A—
11.6K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

21
MJ
Meng JessicaChief Commercial Officer
CDNACareDx, Inc.
Grant or award
A—
60.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

16
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Tax withholding
F$79K
3,859 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

25
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$91K
4,441 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC FORM 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$61K
2,970 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

12
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$408K
19.3K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC FORM 4

Evidence

6
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$4,200
200 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

14
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$214K
10.2K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

24
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$134K
7,007 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

17
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$5,648
286 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

21
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$42K
2,688 sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC FORM 4

Evidence

9
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$32K
2,152 sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Valantine HannahDirector · Jun 16, 2026
  • ← Insider ofevidence
    Meng JessicaChief Commercial Officer · Feb 4, 2026
  • ← Insider ofevidence
    Smith NathanChief Financial Officer · Feb 4, 2026
  • ← Insider ofevidence
    Hanna John Walter JRDirector, President and CEO · Jan 20, 2026
  • ← Insider ofevidence
    Novack Jeffrey AdamSecretary and General Counsel · Nov 7, 2025

    • Lobbying

    $230K reported · de-duplicated
    2026 Q2 $90K in-house2026 Q1 $140K in-house
    • In-house report$90K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • TODD STRATEGY GROUP$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • In-house report$140K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • TODD STRATEGY GROUP$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.